Estimating domain orientation of two human antibody IgG4 chimeras by crystallohydrodynamics

被引:16
|
作者
Longman, E [1 ]
Kreusel, K
Tendler, SB
Fiebrig, I
King, K
Adair, J
O'Shea, P
Ortega, A
de la Torre, JG
Harding, SE
机构
[1] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, England
[2] Univ Nottingham, Nottingham NG7 2GG, England
[3] Pfizer Ltd, Sittingbourne ME9 8AG, Kent, England
[4] Celltech Ltd, Therapeut, Slough SL1 4EN, Berks, England
[5] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England
[6] Univ Murcia, Fac Quim, Dept Quim Fis, E-30071 Murcia, Spain
基金
英国生物技术与生命科学研究理事会;
关键词
chimeras; crystallohydrodynamics; disulfide bridging; human immunoglobulin;
D O I
10.1007/s00249-003-0314-y
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
A modified crystallohydrodynamic approach introduced in 2001 is applied to two human IgG4 constructs from mouse IgG1. The constructs were point mutants of the chimeric antibody molecule cB72.3(gamma4): cB72.3(gamma4A), devoid of inter-chain disulfide bridging, and cB72.3(gamma4P), which has full inter-chain bridging. As before, the known crystallographic structures for the Fab and Fc domains were combined with the measured translational frictional ratios to obtain an estimate for the apparent time-averaged hydration of the domains and hence for that of the intact molecule. The original approach was modified with the hydrated dimensions of the domains being applied, rather than the anhydrous crystallographic dimensions, for assessing the inter-domain orientations using the algorithms HYDROSUB and SOLPRO. Both chimeric IgG4 molecules were found to have open, rather than compact, structures, in agreement with the previous study on wild-type human IgG4. The insertion of a frictionless connector between the domains was necessary, however, for representing the cB72.3(gamma4A) chimera. It therefore appears that the inter-chain disulfide bonds act as physical constraints in the cB72.3(gamma4P) chimera, forcing the antibody domains together and producing a less elongated structure than that of cB72.3(gamma4A). The open structures produced for the two IgG4 chimeras showed similarity to those structures identified for murine IgG1 and IgG2a molecules through X-ray crystallography.
引用
收藏
页码:503 / 510
页数:8
相关论文
共 50 条
  • [1] Estimating domain orientation of two human antibody IgG4 chimeras by crystallohydrodynamics
    Emma Longman
    Katja Kreusel
    Saul B. Tendler
    Immo Fiebrig
    Kevin King
    John Adair
    Paul O'Shea
    Alvaro Ortega
    Jose Garcia de la Torre
    Stephen E. Harding
    European Biophysics Journal, 2003, 32 : 503 - 510
  • [2] PROMINENCE OF IGG4 IN THE IGG ANTIBODY-RESPONSE TO HUMAN FILARIASIS
    OTTESEN, EA
    SKVARIL, F
    TRIPATHY, SP
    POINDEXTER, RW
    HUSSAIN, R
    JOURNAL OF IMMUNOLOGY, 1985, 134 (04): : 2707 - 2712
  • [3] IGG4 AS A BLOCKING ANTIBODY
    AALBERSE, RC
    DIEGES, PH
    KNULBRETLOVA, V
    VOOREN, P
    AALBERS, M
    VANLEEUWEN, J
    CLINICAL REVIEWS IN ALLERGY, 1983, 1 (02): : 289 - 302
  • [4] HUMAN IGG4 MONOCLONAL-ANTIBODY WITH SPECIFICITY TO MELANOMA
    GLASSY, M
    MCKNIGHT, M
    MUKERJEE, S
    GALINDO, J
    MEDENICA, R
    FASEB JOURNAL, 1995, 9 (04): : A1045 - A1045
  • [5] ENHANCED DIAGNOSTIC SPECIFICITY IN HUMAN FILARIASIS BY IGG4 ANTIBODY ASSESSMENT
    LAL, RB
    OTTESEN, EA
    JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (05): : 1034 - 1037
  • [6] Mechanistic modeling of a human IgG4 monoclonal antibody (tralokinumab) Fab-arm exchange with endogenous IgG4 in healthy volunteers
    Wang, Bing
    Goodman, Jo
    Roskos, Lorin K.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (04): : 438 - 446
  • [7] IGG4 SUBCLASS ANTIBODY SEROLOGY FOR ONCHOCERCIASIS
    WEIL, GJ
    OGUNRINADE, AF
    CHANDRASHEKAR, R
    KALE, OO
    JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (03): : 549 - 554
  • [8] Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri®) with endogenous IgG4
    Shapiro, Renee I.
    Plavina, Tatiana
    Schlain, Brian R.
    Pepinsky, R. Blake
    Garber, Ellen A.
    Jarpe, Matthew
    Hochman, Paula S.
    Wehner, Nancy G.
    Bard, Frederique
    Motter, Ruth
    Yednock, Ted A.
    Taylor, Frederick R.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 55 (01) : 168 - 175
  • [9] IGG4 CHIMERIC MOUSE HUMAN-ANTIBODY MEDIATES LYMPHOCYTE ADCC
    TILDEN, AB
    LOBUGLIO, AF
    SHAW, DR
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 361 - 361
  • [10] A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans
    Isaacs, JD
    Wing, MG
    Greenwood, JD
    Hazleman, BL
    Hale, G
    Waldmann, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (03): : 427 - 433